Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Tanespimycin (17-AAG) LNP,tanspiramycin (17-AAG) liposome |
| Catalog Number | R-ZZTBSSDL-109 |
| Alias | Geldanamycin derivative liposome delivery system |
| Appearance | Light yellow to amber homogeneous suspension |
| Molecular Formula | N/A |
| Solubility | Can be reconstituted in physiological buffer or 5% glucose solution to form a stable colloidal dispersion system |
| Storage | 4°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | Development of nano-delivery system for poorly soluble HSP90 inhibitors |
| Specification | 10mg:Inquiry 20mg:Inquiry 50mg:Inquiry |
| Description | Tanespimycin (17-AAG) LNP is a specialized nanoliposome formulation of the heat shock protein 90 inhibitor tanspiromycin (Tanespimycin, 17-AAG). 17-AAG, as a water-soluble derivative of geldanamycin, specifically binds to the ATP-binding pocket of HSP90 and induces the ubiquitination and degradation of its proteins (such as various kinases and transcription factors), thereby interfering with the proliferation, survival and metastasis signaling pathways of tumor cells. Although its water solubility is improved compared with the parent compound, it still faces challenges such as insufficient solubility, rapid metabolism in the body, and lack of tumor targeting. |